Characterizing the Effects of Protein Glycosylation Perturbation on Phosphorylation Signaling
Analytical Chemistry · 30.06.2026 · 98 (25) · 18577-18595
DOI: 10.1021/acs.analchem.6c00790 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 15.06.2026. Verfasst von Effram Wei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, Johns Hopkins Whiting School of Engineering, Baltimore, Maryland 21218, United States. Hauptthemen laut MEDLINE: Signal Transduction. Die Arbeit nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Protein glycosylation and phosphorylation constitute two pervasive regulatory layers in mammalian cells, yet the effects that protein glycosylation play in phosphorylation signaling remain poorly understood. Here we show that controlled perturbation of N-linked glycan biosynthesis through glycoengineering fundamentally rewires phosphorylation signaling networks in human cells. Using comprehensive proteomics approaches, we simultaneously profiled the global proteome, glycoproteome, and phosphoproteome in engineered HEK293 cells designed to eliminate core fucosylation while enhancing sialylation and reducing GlcNAc branching complexity. Glycoengineering emerged as the dominant source of molecular variation across all datasets, with over 9,800 intact glycopeptides identified of which 3,400 are significantly altered, establishing a remodeled baseline cellular state. Upon serum stimulation, engineered cells not only exhibited markedly decreased phosphorylation responses compared to wild-type cells, but comprehensively re-wired to prefer signaling away from canonical EGFR/mTOR growth pathways. These findings establish a systematic framework for targeting glycosylation-phosphorylation regulation and nominate glycan-dependent signaling nodes as potential therapeutic vulnerabilities in glycosylation-remodeled disease states.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biomolecular Engineering, Johns Hopkins Whiting School of Engineering, Baltimore, Maryland 21218, United States.
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, United States.
ORCID-Profile: Effram Wei, Hongyi Liu, Michael Betenbaugh, Hui Zhang
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Wei, E., Liu, H., Betenbaugh, M., & Zhang, H. (2026). Characterizing the Effects of Protein Glycosylation Perturbation on Phosphorylation Signaling. Analytical Chemistry, 98(25), 18577-18595. https://doi.org/10.1021/acs.analchem.6c00790
Vancouver
Wei E, Liu H, Betenbaugh M, Zhang H. Characterizing the Effects of Protein Glycosylation Perturbation on Phosphorylation Signaling. Analytical Chemistry. 2026;98(25):18577-18595. doi:10.1021/acs.analchem.6c00790
BibTeX
@article{Wei2026,
author = {Wei, Effram and Liu, Hongyi and Betenbaugh, Michael and Zhang, Hui},
title = {Characterizing the Effects of Protein Glycosylation Perturbation on Phosphorylation Signaling},
journal = {Analytical Chemistry},
year = {2026},
volume = {98},
number = {25},
pages = {18577--18595},
doi = {10.1021/acs.analchem.6c00790}
}
EUVIMED